Share Price and Basic Stock Data
Last Updated: November 28, 2025, 7:51 am
| PEG Ratio | 3.50 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Coromandel International Ltd, a prominent player in the fertiliser industry, reported a current price of ₹2,367 and a market capitalization of ₹69,785 Cr. The company has demonstrated significant growth in revenue over the years, with sales rising from ₹10,053 Cr in FY 2014 to ₹29,628 Cr in FY 2023. This upward trajectory reflects a robust compound annual growth rate (CAGR) of approximately 12.9% over the past decade. However, the sales for FY 2024 showed a decline to ₹22,058 Cr, followed by a recovery to ₹24,085 Cr in FY 2025. The quarterly sales data indicates fluctuations, with the latest quarter (Jun 2025) recording sales of ₹7,042 Cr. The operational performance has been supported by a diversified product portfolio, including various fertilisers, which cater to agricultural needs. The overall demand for fertilisers in India remains strong, driven by the country’s agricultural sector, which contributes significantly to the GDP.
Profitability and Efficiency Metrics
Coromandel International’s profitability metrics have shown resilience, with a reported net profit of ₹2,381 Cr for the trailing twelve months (TTM). The operating profit margin (OPM) stood at 11%, indicating effective cost management despite the fluctuations in sales. The company recorded a return on equity (ROE) of 16.9% and a return on capital employed (ROCE) of 23.2%, which are commendable figures within the fertiliser sector. The interest coverage ratio (ICR) is notably high at 11.38x, demonstrating the company’s ability to cover its interest obligations comfortably. However, the OPM has varied, reaching a peak of 15% in September 2023, suggesting that while profitability remains stable, there is potential for improvement in operational efficiency. The company’s ability to generate profit from its revenues positions it favorably compared to sector norms, where average OPMs typically range between 10% to 15%.
Balance Sheet Strength and Financial Ratios
Coromandel International’s balance sheet reflects a strong financial position, with total assets amounting to ₹18,917 Cr and reserves of ₹12,149 Cr as of FY 2025. The borrowings are relatively low at ₹1,471 Cr, resulting in a debt-to-equity ratio of 0.02, which indicates a conservative leverage position. The company’s book value per share has increased to ₹376.37, reflecting solid equity growth. The current ratio stands at 1.89, suggesting that Coromandel can cover its short-term liabilities comfortably. Additionally, the inventory turnover ratio of 2.75x indicates efficient inventory management, though it has decreased from previous years. The enterprise value (EV) to net operating revenue ratio is 2.29x, which, while higher than typical sector averages, reflects investor confidence in future growth potential. Overall, the company’s balance sheet strength, characterized by low debt levels and substantial reserves, positions it well for future investments and expansions.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Coromandel International indicates a stable ownership structure, with promoters holding 56.88% of the company’s shares. Foreign institutional investors (FIIs) have increased their stake to 14.45%, reflecting growing confidence among global investors in the company’s growth prospects. Domestic institutional investors (DIIs) hold 15.88%, while the public holds 12.70%. The number of shareholders has risen to 143,977, indicating increased retail interest in the company. Over the past year, FIIs have notably increased their holdings from 7.56% in June 2023 to 14.45% in September 2025, demonstrating a positive shift in investor sentiment. This trend is significant as it reflects confidence in Coromandel’s operational stability and growth potential amidst a competitive landscape. The consistent promoter holdings suggest a commitment to long-term growth, further enhancing investor confidence.
Outlook, Risks, and Final Insight
Looking ahead, Coromandel International is well-positioned to capitalize on the growth opportunities within the fertiliser sector, driven by increasing agricultural demand in India. However, risks remain, including potential fluctuations in raw material prices and regulatory changes that could impact profit margins. Additionally, the company faces competition from both domestic and international players, which could affect market share. A key strength is its robust financial health, marked by low debt and strong profitability metrics, which provide a buffer against market volatilities. Should the company effectively manage its operational efficiency and navigate external challenges, it could enhance its market position. Conversely, failure to adapt to changing market conditions could dampen growth prospects. Overall, Coromandel International’s strategic focus on innovation and sustainability may serve as a catalyst for future success in the evolving agricultural landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Coromandel International Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat State Fertilizers & Chemicals Ltd | 7,340 Cr. | 184 | 231/156 | 11.0 | 313 | 2.72 % | 6.18 % | 4.77 % | 2.00 |
| Bharat Agri Fert & Realty Ltd | 161 Cr. | 30.5 | 85.0/30.0 | 9.97 | 0.00 % | 6.14 % | 14.8 % | 1.00 | |
| Basant Agro Tech (India) Ltd | 115 Cr. | 12.7 | 20.5/11.0 | 22.9 | 20.0 | 0.37 % | 6.52 % | 2.36 % | 1.00 |
| Zuari Agro Chemicals Ltd | 1,149 Cr. | 273 | 395/155 | 3.33 | 602 | 0.00 % | 12.7 % | 9.06 % | 10.0 |
| Southern Petrochemicals Industries Corporation Ltd (SPIC) | 1,752 Cr. | 86.0 | 128/66.2 | 9.42 | 63.8 | 2.32 % | 16.9 % | 13.8 % | 10.0 |
| Industry Average | 10,950.24 Cr | 404.46 | 50.49 | 185.81 | 0.94% | 13.03% | 10.58% | 6.96 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,729 | 10,113 | 8,310 | 5,476 | 5,693 | 6,988 | 5,464 | 3,913 | 4,729 | 7,433 | 6,935 | 4,988 | 7,042 |
| Expenses | 5,044 | 9,056 | 7,539 | 5,089 | 4,988 | 5,933 | 5,115 | 3,650 | 4,238 | 6,471 | 6,222 | 4,579 | 6,260 |
| Operating Profit | 685 | 1,057 | 771 | 387 | 706 | 1,055 | 349 | 263 | 490 | 962 | 713 | 409 | 782 |
| OPM % | 12% | 10% | 9% | 7% | 12% | 15% | 6% | 7% | 10% | 13% | 10% | 8% | 11% |
| Other Income | 55 | 32 | 40 | 47 | 44 | 45 | 59 | 84 | 54 | 65 | 114 | 473 | 84 |
| Interest | 27 | 54 | 57 | 52 | 41 | 46 | 38 | 62 | 57 | 66 | 73 | 66 | 68 |
| Depreciation | 45 | 46 | 47 | 45 | 48 | 54 | 64 | 63 | 65 | 69 | 71 | 85 | 121 |
| Profit before tax | 669 | 989 | 706 | 337 | 661 | 1,000 | 306 | 222 | 422 | 892 | 683 | 731 | 677 |
| Tax % | 25% | 25% | 25% | 27% | 25% | 25% | 25% | 26% | 27% | 26% | 26% | 21% | 26% |
| Net Profit | 499 | 741 | 527 | 246 | 494 | 755 | 228 | 164 | 309 | 659 | 508 | 578 | 502 |
| EPS in Rs | 16.99 | 25.20 | 17.92 | 8.38 | 16.80 | 25.71 | 7.85 | 5.45 | 10.56 | 22.55 | 17.37 | 19.67 | 17.13 |
Last Updated: August 1, 2025, 10:30 pm
Below is a detailed analysis of the quarterly data for Coromandel International Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 7,042.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,988.00 Cr. (Mar 2025) to 7,042.00 Cr., marking an increase of 2,054.00 Cr..
- For Expenses, as of Jun 2025, the value is 6,260.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,579.00 Cr. (Mar 2025) to 6,260.00 Cr., marking an increase of 1,681.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 782.00 Cr.. The value appears strong and on an upward trend. It has increased from 409.00 Cr. (Mar 2025) to 782.00 Cr., marking an increase of 373.00 Cr..
- For OPM %, as of Jun 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Mar 2025) to 11.00%, marking an increase of 3.00%.
- For Other Income, as of Jun 2025, the value is 84.00 Cr.. The value appears to be declining and may need further review. It has decreased from 473.00 Cr. (Mar 2025) to 84.00 Cr., marking a decrease of 389.00 Cr..
- For Interest, as of Jun 2025, the value is 68.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 66.00 Cr. (Mar 2025) to 68.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 121.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 85.00 Cr. (Mar 2025) to 121.00 Cr., marking an increase of 36.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 677.00 Cr.. The value appears to be declining and may need further review. It has decreased from 731.00 Cr. (Mar 2025) to 677.00 Cr., marking a decrease of 54.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Mar 2025) to 26.00%, marking an increase of 5.00%.
- For Net Profit, as of Jun 2025, the value is 502.00 Cr.. The value appears to be declining and may need further review. It has decreased from 578.00 Cr. (Mar 2025) to 502.00 Cr., marking a decrease of 76.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 17.13. The value appears to be declining and may need further review. It has decreased from 19.67 (Mar 2025) to 17.13, marking a decrease of 2.54.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:32 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10,053 | 11,306 | 11,481 | 10,031 | 11,083 | 13,225 | 13,137 | 14,182 | 19,111 | 29,628 | 22,058 | 24,085 | 28,620 |
| Expenses | 9,246 | 10,450 | 10,712 | 9,048 | 9,822 | 11,775 | 11,400 | 12,193 | 16,954 | 26,726 | 19,678 | 21,508 | 25,569 |
| Operating Profit | 808 | 856 | 769 | 983 | 1,261 | 1,450 | 1,737 | 1,989 | 2,156 | 2,902 | 2,380 | 2,577 | 3,051 |
| OPM % | 8% | 8% | 7% | 10% | 11% | 11% | 13% | 14% | 11% | 10% | 11% | 11% | 11% |
| Other Income | 46 | 50 | 87 | 54 | 55 | 8 | 35 | 76 | 141 | 171 | 223 | 703 | 787 |
| Interest | 240 | 210 | 221 | 224 | 178 | 251 | 235 | 106 | 75 | 190 | 187 | 262 | 309 |
| Depreciation | 96 | 105 | 106 | 101 | 99 | 114 | 158 | 173 | 173 | 182 | 229 | 290 | 378 |
| Profit before tax | 517 | 592 | 529 | 712 | 1,038 | 1,093 | 1,379 | 1,786 | 2,050 | 2,701 | 2,188 | 2,728 | 3,151 |
| Tax % | 29% | 32% | 32% | 33% | 33% | 34% | 23% | 26% | 25% | 25% | 25% | 25% | |
| Net Profit | 365 | 402 | 357 | 477 | 691 | 720 | 1,065 | 1,329 | 1,528 | 2,013 | 1,641 | 2,055 | 2,381 |
| EPS in Rs | 12.59 | 13.80 | 12.27 | 16.35 | 23.64 | 24.63 | 36.36 | 45.30 | 52.08 | 68.46 | 55.78 | 70.14 | 81.48 |
| Dividend Payout % | 36% | 33% | 33% | 31% | 27% | 26% | 33% | 26% | 23% | 18% | 11% | 21% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 10.14% | -11.19% | 33.61% | 44.86% | 4.20% | 47.92% | 24.79% | 14.97% | 31.74% | -18.48% | 25.23% |
| Change in YoY Net Profit Growth (%) | 0.00% | -21.33% | 44.81% | 11.25% | -40.67% | 43.72% | -23.13% | -9.82% | 16.77% | -50.22% | 43.71% |
Coromandel International Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 13% |
| 3 Years: | 8% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 10% |
| 3 Years: | 4% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 25% |
| 3 Years: | 31% |
| 1 Year: | 33% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 23% |
| 3 Years: | 21% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 2:15 am
Balance Sheet
Last Updated: November 9, 2025, 1:52 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 |
| Reserves | 2,253 | 2,173 | 2,605 | 2,862 | 2,867 | 3,329 | 4,288 | 5,121 | 6,329 | 7,878 | 9,390 | 11,058 | 12,149 |
| Borrowings | 1,843 | 2,288 | 2,677 | 2,228 | 2,728 | 2,954 | 2,019 | 385 | 395 | 393 | 492 | 780 | 1,471 |
| Other Liabilities | 3,481 | 3,872 | 3,871 | 3,526 | 4,224 | 4,261 | 3,812 | 3,360 | 4,532 | 5,934 | 5,933 | 7,049 | 11,086 |
| Total Liabilities | 7,605 | 8,362 | 9,182 | 8,645 | 9,848 | 10,574 | 10,149 | 8,895 | 11,285 | 14,235 | 15,845 | 18,917 | 24,736 |
| Fixed Assets | 1,734 | 1,380 | 1,320 | 1,328 | 1,327 | 1,309 | 2,032 | 2,015 | 2,092 | 2,200 | 3,112 | 4,139 | 5,574 |
| CWIP | 74 | 46 | 42 | 22 | 48 | 191 | 65 | 90 | 141 | 399 | 235 | 396 | 938 |
| Investments | 342 | 352 | 477 | 388 | 221 | 201 | 211 | 214 | 243 | 287 | 854 | 1,031 | 3,079 |
| Other Assets | 5,455 | 6,583 | 7,343 | 6,907 | 8,252 | 8,873 | 7,840 | 6,576 | 8,809 | 11,348 | 11,644 | 13,351 | 15,144 |
| Total Assets | 7,605 | 8,362 | 9,182 | 8,645 | 9,848 | 10,574 | 10,149 | 8,895 | 11,285 | 14,235 | 15,845 | 18,917 | 24,736 |
Below is a detailed analysis of the balance sheet data for Coromandel International Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00 Cr..
- For Reserves, as of Sep 2025, the value is 12,149.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,058.00 Cr. (Mar 2025) to 12,149.00 Cr., marking an increase of 1,091.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,471.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 780.00 Cr. (Mar 2025) to 1,471.00 Cr., marking an increase of 691.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 11,086.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,049.00 Cr. (Mar 2025) to 11,086.00 Cr., marking an increase of 4,037.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 24,736.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18,917.00 Cr. (Mar 2025) to 24,736.00 Cr., marking an increase of 5,819.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 5,574.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,139.00 Cr. (Mar 2025) to 5,574.00 Cr., marking an increase of 1,435.00 Cr..
- For CWIP, as of Sep 2025, the value is 938.00 Cr.. The value appears strong and on an upward trend. It has increased from 396.00 Cr. (Mar 2025) to 938.00 Cr., marking an increase of 542.00 Cr..
- For Investments, as of Sep 2025, the value is 3,079.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,031.00 Cr. (Mar 2025) to 3,079.00 Cr., marking an increase of 2,048.00 Cr..
- For Other Assets, as of Sep 2025, the value is 15,144.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,351.00 Cr. (Mar 2025) to 15,144.00 Cr., marking an increase of 1,793.00 Cr..
- For Total Assets, as of Sep 2025, the value is 24,736.00 Cr.. The value appears strong and on an upward trend. It has increased from 18,917.00 Cr. (Mar 2025) to 24,736.00 Cr., marking an increase of 5,819.00 Cr..
Notably, the Reserves (12,149.00 Cr.) exceed the Borrowings (1,471.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 807.00 | 854.00 | 767.00 | 981.00 | -1.00 | -1.00 | -1.00 | -384.00 | -393.00 | -391.00 | -490.00 | -778.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 47 | 52 | 59 | 52 | 50 | 48 | 14 | 5 | 7 | 23 | 19 |
| Inventory Days | 86 | 96 | 98 | 88 | 109 | 127 | 109 | 98 | 94 | 69 | 102 | 98 |
| Days Payable | 132 | 131 | 135 | 150 | 162 | 147 | 135 | 110 | 100 | 83 | 117 | 123 |
| Cash Conversion Cycle | 7 | 12 | 15 | -3 | -2 | 30 | 22 | 2 | -1 | -7 | 8 | -7 |
| Working Capital Days | 4 | 11 | 24 | 40 | 27 | 42 | 65 | 64 | 41 | 37 | 44 | 28 |
| ROCE % | 16% | 19% | 15% | 18% | 23% | 23% | 26% | 32% | 35% | 38% | 26% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Kotak Emerging Equity Fund - Regular Plan | 7,423,311 | 2.51 | 850.93 | 7,423,311 | 2025-04-22 17:25:38 | 0% |
| DSP Mid Cap Fund | 5,065,035 | 3.86 | 580.61 | 5,065,035 | 2025-04-22 17:25:38 | 0% |
| Axis Midcap Fund | 4,652,378 | 2.35 | 533.3 | 4,652,378 | 2025-04-22 17:25:38 | 0% |
| SBI Magnum Midcap Fund | 3,778,182 | 3.27 | 433.09 | 3,778,182 | 2025-04-22 17:25:38 | 0% |
| Kotak Equity Opportunities Fund - Regular Plan | 2,450,000 | 1.81 | 280.84 | 2,450,000 | 2025-04-22 17:25:38 | 0% |
| Franklin India Prima Fund | 1,986,228 | 2.59 | 227.68 | 1,986,228 | 2025-04-22 17:25:38 | 0% |
| Sundaram Mid Cap Fund | 1,773,595 | 2.32 | 203.31 | 1,773,595 | 2025-04-22 17:25:38 | 0% |
| Sundaram Mid Cap Fund - Institutional Plan | 1,773,595 | 2.32 | 203.31 | 1,773,595 | 2025-04-22 17:25:38 | 0% |
| SBI Contra Fund | 1,771,410 | 1.24 | 203.06 | 1,771,410 | 2025-04-22 17:25:38 | 0% |
| DSP Equity Opportunities Fund | 1,298,134 | 1.63 | 148.81 | 1,298,134 | 2025-04-22 17:25:38 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 70.23 | 55.81 | 68.51 | 52.09 | 45.34 |
| Diluted EPS (Rs.) | 70.12 | 55.81 | 68.38 | 51.98 | 45.22 |
| Cash EPS (Rs.) | 81.42 | 64.39 | 75.49 | 57.83 | 51.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 376.37 | 320.88 | 268.97 | 216.64 | 175.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 376.37 | 320.88 | 268.97 | 216.64 | 175.55 |
| Revenue From Operations / Share (Rs.) | 817.56 | 749.27 | 1007.75 | 651.14 | 483.37 |
| PBDIT / Share (Rs.) | 101.39 | 89.34 | 105.35 | 78.16 | 70.19 |
| PBIT / Share (Rs.) | 91.54 | 81.57 | 99.16 | 72.28 | 64.29 |
| PBT / Share (Rs.) | 94.40 | 75.24 | 92.70 | 69.71 | 60.69 |
| Net Profit / Share (Rs.) | 71.56 | 56.63 | 69.30 | 51.95 | 45.12 |
| NP After MI And SOA / Share (Rs.) | 70.14 | 55.78 | 68.47 | 52.08 | 45.30 |
| PBDIT Margin (%) | 12.40 | 11.92 | 10.45 | 12.00 | 14.52 |
| PBIT Margin (%) | 11.19 | 10.88 | 9.83 | 11.10 | 13.30 |
| PBT Margin (%) | 11.54 | 10.04 | 9.19 | 10.70 | 12.55 |
| Net Profit Margin (%) | 8.75 | 7.55 | 6.87 | 7.97 | 9.33 |
| NP After MI And SOA Margin (%) | 8.57 | 7.44 | 6.79 | 7.99 | 9.37 |
| Return on Networth / Equity (%) | 18.63 | 17.43 | 25.45 | 24.03 | 25.80 |
| Return on Capital Employeed (%) | 22.59 | 24.04 | 34.79 | 31.11 | 33.71 |
| Return On Assets (%) | 10.91 | 10.35 | 14.14 | 13.54 | 14.94 |
| Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 1.39 | 1.47 | 2.32 | 1.90 | 1.48 |
| Current Ratio (X) | 1.89 | 2.07 | 1.75 | 1.87 | 1.98 |
| Quick Ratio (X) | 1.21 | 1.28 | 0.99 | 1.05 | 1.19 |
| Inventory Turnover Ratio (X) | 2.75 | 3.00 | 4.84 | 3.80 | 2.65 |
| Dividend Payout Ratio (NP) (%) | 17.08 | 10.75 | 17.51 | 23.03 | 39.70 |
| Dividend Payout Ratio (CP) (%) | 14.98 | 9.44 | 16.06 | 20.70 | 35.12 |
| Earning Retention Ratio (%) | 82.92 | 89.25 | 82.49 | 76.97 | 60.30 |
| Cash Earning Retention Ratio (%) | 85.02 | 90.56 | 83.94 | 79.30 | 64.88 |
| Interest Coverage Ratio (X) | 11.38 | 14.10 | 16.30 | 30.40 | 19.49 |
| Interest Coverage Ratio (Post Tax) (X) | 7.71 | 9.94 | 11.72 | 21.20 | 13.53 |
| Enterprise Value (Cr.) | 55161.09 | 28896.11 | 24436.79 | 21701.81 | 21993.08 |
| EV / Net Operating Revenue (X) | 2.29 | 1.31 | 0.82 | 1.14 | 1.55 |
| EV / EBITDA (X) | 18.47 | 10.99 | 7.89 | 9.46 | 10.68 |
| MarketCap / Net Operating Revenue (X) | 2.42 | 1.44 | 0.87 | 1.23 | 1.60 |
| Retention Ratios (%) | 82.91 | 89.24 | 82.48 | 76.96 | 60.29 |
| Price / BV (X) | 5.26 | 3.36 | 3.27 | 3.69 | 4.41 |
| Price / Net Operating Revenue (X) | 2.42 | 1.44 | 0.87 | 1.23 | 1.60 |
| EarningsYield | 0.03 | 0.05 | 0.07 | 0.06 | 0.05 |
After reviewing the key financial ratios for Coromandel International Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 70.23. This value is within the healthy range. It has increased from 55.81 (Mar 24) to 70.23, marking an increase of 14.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is 70.12. This value is within the healthy range. It has increased from 55.81 (Mar 24) to 70.12, marking an increase of 14.31.
- For Cash EPS (Rs.), as of Mar 25, the value is 81.42. This value is within the healthy range. It has increased from 64.39 (Mar 24) to 81.42, marking an increase of 17.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 376.37. It has increased from 320.88 (Mar 24) to 376.37, marking an increase of 55.49.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 376.37. It has increased from 320.88 (Mar 24) to 376.37, marking an increase of 55.49.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 817.56. It has increased from 749.27 (Mar 24) to 817.56, marking an increase of 68.29.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 101.39. This value is within the healthy range. It has increased from 89.34 (Mar 24) to 101.39, marking an increase of 12.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 91.54. This value is within the healthy range. It has increased from 81.57 (Mar 24) to 91.54, marking an increase of 9.97.
- For PBT / Share (Rs.), as of Mar 25, the value is 94.40. This value is within the healthy range. It has increased from 75.24 (Mar 24) to 94.40, marking an increase of 19.16.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 71.56. This value is within the healthy range. It has increased from 56.63 (Mar 24) to 71.56, marking an increase of 14.93.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 70.14. This value is within the healthy range. It has increased from 55.78 (Mar 24) to 70.14, marking an increase of 14.36.
- For PBDIT Margin (%), as of Mar 25, the value is 12.40. This value is within the healthy range. It has increased from 11.92 (Mar 24) to 12.40, marking an increase of 0.48.
- For PBIT Margin (%), as of Mar 25, the value is 11.19. This value is within the healthy range. It has increased from 10.88 (Mar 24) to 11.19, marking an increase of 0.31.
- For PBT Margin (%), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 10.04 (Mar 24) to 11.54, marking an increase of 1.50.
- For Net Profit Margin (%), as of Mar 25, the value is 8.75. This value is within the healthy range. It has increased from 7.55 (Mar 24) to 8.75, marking an increase of 1.20.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.57. This value is within the healthy range. It has increased from 7.44 (Mar 24) to 8.57, marking an increase of 1.13.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.63. This value is within the healthy range. It has increased from 17.43 (Mar 24) to 18.63, marking an increase of 1.20.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.59. This value is within the healthy range. It has decreased from 24.04 (Mar 24) to 22.59, marking a decrease of 1.45.
- For Return On Assets (%), as of Mar 25, the value is 10.91. This value is within the healthy range. It has increased from 10.35 (Mar 24) to 10.91, marking an increase of 0.56.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.39. It has decreased from 1.47 (Mar 24) to 1.39, marking a decrease of 0.08.
- For Current Ratio (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.89, marking a decrease of 0.18.
- For Quick Ratio (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.28 (Mar 24) to 1.21, marking a decrease of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.75. This value is below the healthy minimum of 4. It has decreased from 3.00 (Mar 24) to 2.75, marking a decrease of 0.25.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 17.08. This value is below the healthy minimum of 20. It has increased from 10.75 (Mar 24) to 17.08, marking an increase of 6.33.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.98. This value is below the healthy minimum of 20. It has increased from 9.44 (Mar 24) to 14.98, marking an increase of 5.54.
- For Earning Retention Ratio (%), as of Mar 25, the value is 82.92. This value exceeds the healthy maximum of 70. It has decreased from 89.25 (Mar 24) to 82.92, marking a decrease of 6.33.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 85.02. This value exceeds the healthy maximum of 70. It has decreased from 90.56 (Mar 24) to 85.02, marking a decrease of 5.54.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 11.38. This value is within the healthy range. It has decreased from 14.10 (Mar 24) to 11.38, marking a decrease of 2.72.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has decreased from 9.94 (Mar 24) to 7.71, marking a decrease of 2.23.
- For Enterprise Value (Cr.), as of Mar 25, the value is 55,161.09. It has increased from 28,896.11 (Mar 24) to 55,161.09, marking an increase of 26,264.98.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.29. This value is within the healthy range. It has increased from 1.31 (Mar 24) to 2.29, marking an increase of 0.98.
- For EV / EBITDA (X), as of Mar 25, the value is 18.47. This value exceeds the healthy maximum of 15. It has increased from 10.99 (Mar 24) to 18.47, marking an increase of 7.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.42. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 2.42, marking an increase of 0.98.
- For Retention Ratios (%), as of Mar 25, the value is 82.91. This value exceeds the healthy maximum of 70. It has decreased from 89.24 (Mar 24) to 82.91, marking a decrease of 6.33.
- For Price / BV (X), as of Mar 25, the value is 5.26. This value exceeds the healthy maximum of 3. It has increased from 3.36 (Mar 24) to 5.26, marking an increase of 1.90.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.42. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 2.42, marking an increase of 0.98.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to 0.03, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Coromandel International Ltd:
- Net Profit Margin: 8.75%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.59% (Industry Average ROCE: 13.03%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.63% (Industry Average ROE: 10.58%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 7.71
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.21
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 32.8 (Industry average Stock P/E: 50.49)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.75%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Fertilisers | Coromandel House, Secunderabad Telangana 500003 | investorsgrievance@coromandel.murugappa.com http://www.coromandel.biz |
| Management | |
|---|---|
| Name | Position Held |
| Mr. A Vellayan | Chairman Emeritus |
| Mr. Arun Alagappan | Executive Chairman |
| Mr. Natrajan Srinivasan | Executive Vice Chairman |
| Mr. S Sankarasubramanian | Managing Director & CEO |
| Dr. Raghuram Devarakonda | Executive Director |
| Mr. Arunachalam Vellayan | Whole Time Director |
| Mr. Narayanan Vellayan | Whole Time Director |
| Mr. Sudarshan Venu | Independent Director |
| Dr. Deepali Pant Joshi | Independent Director |
| Mr. Adnan Ahmad | Independent Director |
| Mr. Aditya Himatsingka | Independent Director |
| Mr. Suresh Subramanian | Independent Director |
| Mr. Durgashankar Subramaniam | Independent Director |
FAQ
What is the intrinsic value of Coromandel International Ltd?
Coromandel International Ltd's intrinsic value (as of 28 November 2025) is 1840.81 which is 22.23% lower the current market price of 2,367.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 69,785 Cr. market cap, FY2025-2026 high/low of 2,720/1,590, reserves of ₹12,149 Cr, and liabilities of 24,736 Cr.
What is the Market Cap of Coromandel International Ltd?
The Market Cap of Coromandel International Ltd is 69,785 Cr..
What is the current Stock Price of Coromandel International Ltd as on 28 November 2025?
The current stock price of Coromandel International Ltd as on 28 November 2025 is 2,367.
What is the High / Low of Coromandel International Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Coromandel International Ltd stocks is 2,720/1,590.
What is the Stock P/E of Coromandel International Ltd?
The Stock P/E of Coromandel International Ltd is 32.8.
What is the Book Value of Coromandel International Ltd?
The Book Value of Coromandel International Ltd is 413.
What is the Dividend Yield of Coromandel International Ltd?
The Dividend Yield of Coromandel International Ltd is 0.51 %.
What is the ROCE of Coromandel International Ltd?
The ROCE of Coromandel International Ltd is 23.2 %.
What is the ROE of Coromandel International Ltd?
The ROE of Coromandel International Ltd is 16.9 %.
What is the Face Value of Coromandel International Ltd?
The Face Value of Coromandel International Ltd is 1.00.